| |
| |
|
| Insider
Information: |
Luly Jay R. |
| Relationship: |
President and CEO, Dir... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
810,609 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,165,037 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
810,609 |
|
|
| Total
Value |
$10,165,037 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 26.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Enanta Pharmaceuticals Inc |
ENTA |
President and CEO, Dir... |
2024-02-12 |
810,609 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-07-06 |
4 |
AS |
$124.26 |
$4,014,892 |
D/D |
(32,023) |
593,026 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-07-05 |
4 |
AS |
$123.81 |
$368,568 |
D/D |
(2,977) |
625,049 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-05-17 |
4 |
AS |
$105.83 |
$1,160,742 |
D/D |
(10,968) |
628,026 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-05-16 |
4 |
AS |
$105.82 |
$1,484,913 |
D/D |
(14,032) |
638,994 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2019-02-12 |
4 |
D |
$88.88 |
$1,842,482 |
D/D |
(20,730) |
631,194 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2021-12-01 |
4 |
D |
$87.68 |
$170,450 |
D/D |
(1,944) |
700,728 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2018-02-12 |
4 |
D |
$76.85 |
$855,439 |
D/D |
(11,132) |
653,026 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2019-12-16 |
4 |
D |
$63.88 |
$212,720 |
D/D |
(3,330) |
642,416 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• – – |
2022-02-14 |
4 |
D |
$62.49 |
$147,164 |
D/D |
(2,355) |
716,464 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2021-09-15 |
4 |
AS |
$59.06 |
$266,698 |
D/D |
(4,516) |
676,972 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-02-13 |
4 |
D |
$52.77 |
$1,086,587 |
D/D |
(20,591) |
799,219 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-02-13 |
4/A |
D |
$52.77 |
$1,086,587 |
D/D |
(20,591) |
819,810 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2020-02-12 |
4 |
D |
$52.76 |
$164,717 |
D/D |
(3,122) |
649,689 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2015-01-05 |
4 |
AS |
$50.23 |
$756,463 |
D/D |
(15,000) |
506,393 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-12-01 |
4 |
AS |
$44.99 |
$680,815 |
D/D |
(15,000) |
514,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2023-03-13 |
4 |
AS |
$44.81 |
$1,260,628 |
D/D |
(27,912) |
819,810 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-12-01 |
4 |
D |
$44.33 |
$250,863 |
D/D |
(5,659) |
773,805 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2022-12-16 |
4 |
AS |
$43.59 |
$1,341,713 |
D/D |
(30,000) |
773,805 |
0 |
% |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2020-12-15 |
4 |
D |
$42.52 |
$93,587 |
D/D |
(2,201) |
681,488 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-11-03 |
4 |
AS |
$42.38 |
$637,812 |
D/D |
(15,000) |
529,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-04-01 |
4 |
AS |
$38.92 |
$587,542 |
D/D |
(15,000) |
544,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-02-14 |
4 |
AS |
$37.81 |
$220,975 |
D/D |
(5,800) |
569,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2014-03-10 |
4 |
AS |
$37.61 |
$384,867 |
D/D |
(10,000) |
559,338 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2015-02-20 |
4 |
AS |
$35.35 |
$530,289 |
D/D |
(15,000) |
491,393 |
0 |
- |
|
| ENTA |
Enanta Pharmaceuticals In... |
President and CEO |
• • – |
2015-03-09 |
4 |
AS |
$33.13 |
$500,521 |
D/D |
(15,000) |
476,393 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
